D. Addington, J. Addington, E. Maticka-tyndale, and J. Joyce, Reliability and validity of a depression rating scale for schizophrenics, Schizophr. Res, vol.6, pp.201-208, 1992.

S. A. Aldridge, Drug-induced sexual dysfunction, Clin. Pharm, vol.1, pp.141-147, 1982.

M. Andrianarisoa, L. Boyer, O. Godin, L. Brunel, E. Bulzacka et al., Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort, Schizophr. Res, vol.185, pp.173-181, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01792072

R. Bender and S. Lange, Adjusting for multiple testing-when and how?, J. Clin. Epidemiol, vol.54, pp.343-349, 2001.

M. G. Biebel, A. L. Burnett, and H. Sadeghi-nejad, Male Sexual Function and Smoking. Sex, Med. Rev, vol.4, pp.366-375, 2016.


E. Bulzacka, L. Boyer, F. Schürhoff, O. Godin, F. Berna et al.,

. Group, Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset, Schizophr. Bull, vol.42, pp.1290-1302, 2016.


X. Fan, D. C. Henderson, E. Chiang, L. B. Briggs, O. Freudenreich et al., Sexual functioning, psychopathology and quality of life in patients with schizophrenia, Schizophr. Res, vol.94, pp.119-127, 2007.

G. Fond, L. Boyer, F. Berna, O. Godin, E. Bulzacka et al., Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort, Br. J. Psychiatry J. Ment. Sci, vol.213, pp.464-470, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01814845

G. Fond, O. Godin, L. Boyer, F. Berna, M. Andrianarisoa et al., Chronic lowgrade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort, Eur. Arch. Psychiatry Clin. Neurosci, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02336999

G. Fond, O. Godin, L. Brunel, B. Aouizerate, F. Berna et al., FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group, 2016. Peripheral subinflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set, J. Affect. Disord, vol.191, pp.209-215

G. Fond, N. Hamdani, F. Kapczinski, W. Boukouaci, N. Drancourt et al., Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review, Acta Psychiatr. Scand, vol.129, pp.163-179, 2014.

O. Godin, M. Leboyer, A. Gaman, B. Aouizerate, F. Berna et al., Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort, Schizophr. Res, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01755227

O. Godin, M. Leboyer, F. Schürhoff, P. Llorca, L. Boyer et al., Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia: The FACE-SZ Cohort, J. Clin. Psychiatry, vol.79, 2018.

O. D. Howes, M. J. Wheeler, L. S. Pilowsky, S. Landau, R. M. Murray et al., Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder, J. Clin. Psychiatry, vol.68, pp.361-367, 2007.

J. C. Kaminetsky, V. Stecher, and L. Tseng, Quality of erections by age group in men with erectile dysfunction, Int. J. Clin. Pract, vol.71, 2017.

J. Khoo, C. Piantadosi, R. Duncan, S. G. Worthley, A. Jenkins et al., Comparing effects of a lowenergy diet and a high-protein low-fat diet on sexual and endothelial function, urinary tract symptoms, and inflammation in obese diabetic men, J. Sex. Med, vol.8, pp.2868-2875, 2011.

C. Lançon, P. Auquier, G. Reine, D. Bernard, and M. Toumi, Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS), J. Affect. Disord, vol.58, pp.107-115, 2000.

H. Liu-seifert, B. J. Kinon, C. J. Tennant, J. Sniadecki, and J. Volavka, Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone, Neuropsychiatr. Dis. Treat, vol.5, pp.47-54, 2009.

M. I. Maiorino, G. Bellastella, D. Giugliano, and K. Esposito, From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome, J. Endocrinol. Invest, vol.41, pp.1249-1258, 2018.


J. C. Martín, M. J. Acuña, J. Labrador, M. Blanco, and C. Casas, Sexual dysfunction factors in patients with schizophrenia treated with second generation antipsychotics: not only prolactin, Actas Esp. Psiquiatr, vol.46, pp.217-225, 2018.

D. Misdrahi, A. Tessier, J. Swendsen, F. Berna, L. Brunel et al., FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group, 2016. Determination of Adherence Profiles in Schizophrenia Using Self-Reported Adherence: Results From the FACE-SZ Dataset, J. Clin. Psychiatry, vol.77, pp.1130-1136


R. Porto, , 2014.

P. Fr, , vol.43, pp.1111-1115, 1983.

S. P. Prall and M. P. Muehlenbein, DHEA Modulates Immune Function: A Review of Evidence, Vitam. Horm, vol.108, pp.125-144, 2018.


E. Rubio-abadal, N. Del-cacho, G. Saenz-navarrete, B. Arranz, R. Cambra et al., How Hyperprolactinemia Affects Sexual Function in Patients Under Antipsychotic Treatment, J. Clin. Psychopharmacol, vol.36, pp.422-428, 2016.

K. Rutkowski, P. Sowa, J. Rutkowska-talipska, A. Kuryliszyn-moskal, and R. Rutkowski, Dehydroepiandrosterone (DHEA): hypes and hopes, Drugs, vol.74, pp.1195-1207, 2014.

D. Santi, A. R. Granata, A. Guidi, E. Pignatti, T. Trenti et al., Six months of daily treatment with vardenafil improves parameters of endothelial inflammation and of hypogonadism in male patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, prospective trial, Eur. J. Endocrinol, vol.174, pp.513-522, 2016.


F. Schürhoff, G. Fond, F. Berna, E. Bulzacka, O. Godin et al., FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group, 2018.

. L'encephale,

F. Schürhoff, G. Fond, F. Berna, E. Bulzacka, J. Vilain et al., FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) collaborators, 2015. A National network of schizophrenia expert centres: An innovative tool to bridge the researchpractice gap, Eur. Psychiatry J. Assoc. Eur. Psychiatr

S. M. Smith, V. O'keane, and R. Murray, Sexual dysfunction in patients taking conventional antipsychotic medication, Br. J. Psychiatry J. Ment. Sci, vol.181, pp.49-55, 2002.

V. Soria, A. González-rodríguez, E. Huerta-ramos, J. Usall, J. Cobo et al., Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis, Psychoneuroendocrinology, vol.93, pp.8-19, 2018.

T. S. Stroup and N. Gray, Management of common adverse effects of antipsychotic medications. World Psychiatry Off, J. World Psychiatr. Assoc. WPA, vol.17, pp.341-356, 2018.

A. Uçok, C. Incesu, T. Aker, and S. Erkoç, Sexual dysfunction in patients with schizophrenia on antipsychotic medication, Eur. Psychiatry J. Assoc. Eur. Psychiatr, vol.22, pp.328-333, 2007.